Immune cell 'Double Punch' tested against tough lymphomas
NCT ID NCT04074746
Summary
This study tested a two-part treatment for patients whose Hodgkin or Non-Hodgkin lymphoma had returned or didn't respond to other therapies. First, patients received specially prepared immune cells (NK cells) loaded with an antibody called AFM13. Then, they received the AFM13 antibody alone. The goal was to see if this combination was safe and could help the body's immune system better attack and shrink the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CLASSIC HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.